VELIVET Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Velivet, and what generic alternatives are available?
Velivet is a drug marketed by Duramed Pharms Barr and is included in one NDA.
The generic ingredient in VELIVET is desogestrel; ethinyl estradiol. There are eight drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the desogestrel; ethinyl estradiol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Velivet
A generic version of VELIVET was approved as desogestrel; ethinyl estradiol by DURAMED PHARMS BARR on August 12th, 1999.
Summary for VELIVET
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 4 |
Patent Applications: | 295 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for VELIVET |
Drug Sales Revenues: | Drug sales revenues for VELIVET |
DailyMed Link: | VELIVET at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for VELIVET
US Patents and Regulatory Information for VELIVET
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Duramed Pharms Barr | VELIVET | desogestrel; ethinyl estradiol | TABLET;ORAL-28 | 076455-001 | Feb 24, 2004 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |